BDBM287715 US10085984, Example 93::US11040034, Ex. No. 93

SMILES Cc1nncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1C

InChI Key InChIKey=ZGPAFDNHXLVJPD-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 287715   

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287715(US10085984, Example 93 | US11040034, Ex. No. 93)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287715(US10085984, Example 93 | US11040034, Ex. No. 93)
Affinity DataIC50: 100nMAssay Description:V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
Go to US Patent

TargetCytochrome P450 11B1, mitochondrial(Human)
Viamet Pharmaceuticals (Bermuda)

US Patent
LigandPNGBDBM287715(US10085984, Example 93 | US11040034, Ex. No. 93)
Affinity DataIC50: 750nMAssay Description:V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
Go to US Patent

TargetCytochrome P450 11B1, mitochondrial(Human)
Viamet Pharmaceuticals (Bermuda)

US Patent
LigandPNGBDBM287715(US10085984, Example 93 | US11040034, Ex. No. 93)
Affinity DataIC50: 5.50E+3nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
Go to US Patent